Joel, A., Georgy, J. T., Thumaty, D. B., John, A. O., Chacko, R. T., Rebekah, G., . . . Singh, A. (2021). Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: Patterns of use and clinical outcomes in India. Ecancermedicalscience.
Citación estilo ChicagoJoel, Anjana, et al. "Neoadjuvant Chemotherapy With Biosimilar Trastuzumab in Human Epidermal Growth Factor Receptor 2 Overexpressed Non-metastatic Breast Cancer: Patterns of Use and Clinical Outcomes in India." Ecancermedicalscience 2021.
Cita MLAJoel, Anjana, et al. "Neoadjuvant Chemotherapy With Biosimilar Trastuzumab in Human Epidermal Growth Factor Receptor 2 Overexpressed Non-metastatic Breast Cancer: Patterns of Use and Clinical Outcomes in India." Ecancermedicalscience 2021.